Document is current
Any future updates will be listed below
-
Authors
Kokkinou, Michelle
Irvine, Elaine E.
Bonsall, David R.
Natesan, Sridhar https://orcid.org/0000-0001-7499-1714
Wells, Lisa A.
Smith, Mark
Glegola, Justyna
Paul, Eleanor J. https://orcid.org/0000-0003-1183-9285
Tossell, Kyoko
Veronese, Mattia https://orcid.org/0000-0003-3562-0683
Khadayate, Sanjay
Dedic, Nina
Hopkins, Seth C.
Ungless, Mark A.
Withers, Dominic J.
Howes, Oliver D.
- License Information
-
More Information
Article History
Received: 1 July 2019
Revised: 6 April 2020
Accepted: 17 April 2020
First Online: 7 May 2020
Compliance with ethical standards
:
: MK conducted research funded by Medical Research Council. MV is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. ODH conducts research funded by the Medical Research Council (UK), the National Institute of Health Research (UK) and the Maudsley Charity. ODH has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Eli Lilly, Jansenn, Lundbeck, Lyden-Delta, Mylan, Otsuka, Sunovion and Roche. Neither ODH nor his family have been employed by or have holdings/a financial stake in any biomedical company. ND and SCH are employees of Sunovion Pharmaceuticals. DB and LW are employees of Invicro. EI, SN, MS, JG, EP, KT, SK, MU and DW have no financial interests to disclose.
